{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:01:28Z","timestamp":1791874888369,"version":"4.3.4"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600924"],"award-info":[{"award-number":["81600924"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00415-024-12800-8","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T08:57:18Z","timestamp":1733129838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Dysregulation of energy metabolism in Alzheimer's disease"],"prefix":"10.1007","volume":"272","author":[{"given":"Yue","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2321-6277","authenticated-orcid":false,"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"12800_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","volume":"167","author":"JA Soria Lopez","year":"2019","unstructured":"Soria Lopez JA, Gonz\u00e1lez HM, L\u00e9ger GC (2019) Alzheimer\u2019s disease. Handb Clin Neurol 167:231\u2013255. https:\/\/doi.org\/10.1016\/B978-0-12-804766-8.00013-3","journal-title":"Handb Clin Neurol"},{"key":"12800_CR2","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, Iqbal K, Tung YC et al (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci 83:4913\u20134917. https:\/\/doi.org\/10.1073\/pnas.83.13.4913","journal-title":"Proc Natl Acad Sci"},{"key":"12800_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103242","volume":"75","author":"AG Correas","year":"2024","unstructured":"Correas AG, Olaso-Gonzalez G, Roca M et al (2024) Glucose 6-phosphate dehydrogenase overexpression rescues the loss of cognition in the double transgenic APP\/PS1 mouse model of Alzheimer\u2019s disease. Redox Biol 75:103242. https:\/\/doi.org\/10.1016\/j.redox.2024.103242","journal-title":"Redox Biol"},{"key":"12800_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang W, Zhao F, Ma X et al (2020) Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances. Mol Neurodegener 15:30. https:\/\/doi.org\/10.1186\/s13024-020-00376-6","journal-title":"Mol Neurodegener"},{"key":"12800_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2022.09.032","volume":"193","author":"S Dewanjee","year":"2022","unstructured":"Dewanjee S, Chakraborty P, Bhattacharya H et al (2022) Altered glucose metabolism in Alzheimer\u2019s disease: role of mitochondrial dysfunction and oxidative stress. Free Radic Biol Med 193:134\u2013157. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.09.032","journal-title":"Free Radic Biol Med"},{"key":"12800_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield DA, Halliwell B (2019) Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci 20:148\u2013160. https:\/\/doi.org\/10.1038\/s41583-019-0132-6","journal-title":"Nat Rev Neurosci"},{"key":"12800_CR7","doi-asserted-by":"publisher","first-page":"101191","DOI":"10.1016\/j.arr.2020.101191","volume":"64","author":"JA Pradeepkiran","year":"2020","unstructured":"Pradeepkiran JA, Reddy PH (2020) Defective mitophagy in Alzheimer\u2019s disease. Ageing Res Rev 64:101191. https:\/\/doi.org\/10.1016\/j.arr.2020.101191","journal-title":"Ageing Res Rev"},{"key":"12800_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2016.23","volume":"17","author":"PM Quir\u00f3s","year":"2016","unstructured":"Quir\u00f3s PM, Mottis A, Auwerx J (2016) Mitonuclear communication in homeostasis and stress. Nat Rev Mol Cell Biol 17:213\u2013226. https:\/\/doi.org\/10.1038\/nrm.2016.23","journal-title":"Nat Rev Mol Cell Biol"},{"key":"12800_CR9","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3233\/JAD-160841","volume":"55","author":"L Szablewski","year":"2017","unstructured":"Szablewski L (2017) Glucose transporters in brain. In Health and in Alzheimer\u2019s Disease. J Alzheimers Dis JAD 55:1307\u20131320. https:\/\/doi.org\/10.3233\/JAD-160841","journal-title":"J Alzheimers Dis JAD"},{"key":"12800_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.626636","volume":"15","author":"N Kyrtata","year":"2021","unstructured":"Kyrtata N, Emsley HCA, Sparasci O et al (2021) A systematic review of glucose transport alterations in Alzheimer\u2019s Disease. Front Neurosci 15:626636. https:\/\/doi.org\/10.3389\/fnins.2021.626636","journal-title":"Front Neurosci"},{"key":"12800_CR11","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","volume":"472","author":"H Koepsell","year":"2020","unstructured":"Koepsell H (2020) Glucose transporters in brain in health and disease. Pflugers Arch 472:1299\u20131343. https:\/\/doi.org\/10.1007\/s00424-020-02441-x","journal-title":"Pflugers Arch"},{"key":"12800_CR12","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s12035-019-01743-1","volume":"57","author":"E Gil-Iturbe","year":"2020","unstructured":"Gil-Iturbe E, Solas M, Cuadrado-Tejedo M et al (2020) GLUT12 expression in brain of mouse models of Alzheimer\u2019s Disease. Mol Neurobiol 57:798\u2013805. https:\/\/doi.org\/10.1007\/s12035-019-01743-1","journal-title":"Mol Neurobiol"},{"key":"12800_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nn.3966","volume":"18","author":"EA Winkler","year":"2015","unstructured":"Winkler EA, Nishida Y, Sagare AP et al (2015) GLUT1 reductions exacerbate Alzheimer\u2019s disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci 18:521\u2013530. https:\/\/doi.org\/10.1038\/nn.3966","journal-title":"Nat Neurosci"},{"key":"12800_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/2022.11.21.517280","author":"L Wang","year":"2022","unstructured":"Wang L, Curran GL, Min PH et al (2022) Amyloid beta peptides inhibit glucose transport at the blood\u2013brain barrier by disrupting insulin-Akt pathway in Alzheimer\u2019s Disease. Pharmacol Toxicol. https:\/\/doi.org\/10.1101\/2022.11.21.517280","journal-title":"Pharmacol Toxicol"},{"key":"12800_CR15","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.410350507","volume":"35","author":"IA Simpson","year":"1994","unstructured":"Simpson IA, Chundu KR, Davies-Hill T et al (1994) Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer\u2019s disease. Ann Neurol 35:546\u2013551. https:\/\/doi.org\/10.1002\/ana.410350507","journal-title":"Ann Neurol"},{"key":"12800_CR16","doi-asserted-by":"publisher","first-page":"e69830","DOI":"10.1371\/journal.pone.0069830","volume":"8","author":"H Sancheti","year":"2013","unstructured":"Sancheti H, Akopian G, Yin F et al (2013) Age-dependent modulation of synaptic plasticity and insulin mimetic effect of lipoic acid on a mouse model of Alzheimer\u2019s disease. PLoS ONE 8:e69830. https:\/\/doi.org\/10.1371\/journal.pone.0069830","journal-title":"PLoS ONE"},{"key":"12800_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1006\/exnr.2001.7719","volume":"170","author":"E Uemura","year":"2001","unstructured":"Uemura E, Greenlee HW (2001) Amyloid beta-peptide inhibits neuronal glucose uptake by preventing exocytosis. Exp Neurol 170:270\u2013276. https:\/\/doi.org\/10.1006\/exnr.2001.7719","journal-title":"Exp Neurol"},{"key":"12800_CR18","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.nlm.2010.02.002","volume":"93","author":"EC McNay","year":"2010","unstructured":"McNay EC, Ong CT, McCrimmon RJ et al (2010) Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem 93:546\u2013553. https:\/\/doi.org\/10.1016\/j.nlm.2010.02.002","journal-title":"Neurobiol Learn Mem"},{"key":"12800_CR19","doi-asserted-by":"publisher","unstructured":"Imamura T (2023) The mechanisms of glucose transporter type 4 translocation regulated by insulin receptor signaling. Nihon Yakurigaku Zasshi Folia Pharmacol Jpn. https:\/\/doi.org\/10.1254\/fpj.22106","DOI":"10.1254\/fpj.22106"},{"key":"12800_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3233\/JAD-2012-112192","volume":"30","author":"J Pearson-Leary","year":"2012","unstructured":"Pearson-Leary J, McNay EC (2012) Intrahippocampal administration of amyloid-\u03b2(1\u201342) oligomers acutely impairs spatial working memory, insulin signaling, and hippocampal metabolism. J Alzheimers Dis JAD 30:413\u2013422. https:\/\/doi.org\/10.3233\/JAD-2012-112192","journal-title":"J Alzheimers Dis JAD"},{"key":"12800_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cmet.2007.03.001","volume":"5","author":"H Sano","year":"2007","unstructured":"Sano H, Eguez L, Teruel MN et al (2007) Rab10, a target of the AS160 Rab GAP, is required for insulin-stimulated translocation of GLUT4 to the adipocyte plasma membrane. Cell Metab 5:293\u2013303. https:\/\/doi.org\/10.1016\/j.cmet.2007.03.001","journal-title":"Cell Metab"},{"key":"12800_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2017.09.033","volume":"338","author":"J Pearson-Leary","year":"2018","unstructured":"Pearson-Leary J, Jahagirdar V, Sage J, McNay EC (2018) Insulin modulates hippocampally-mediated spatial working memory via glucose transporter-4. Behav Brain Res 338:32\u201339. https:\/\/doi.org\/10.1016\/j.bbr.2017.09.033","journal-title":"Behav Brain Res"},{"key":"12800_CR23","doi-asserted-by":"publisher","first-page":"11851","DOI":"10.1523\/JNEUROSCI.1700-16.2016","volume":"36","author":"J Pearson-Leary","year":"2016","unstructured":"Pearson-Leary J, McNay EC (2016) Novel roles for the insulin-regulated glucose transporter-4 in hippocampally dependent memory. J Neurosci Off J Soc Neurosci 36:11851\u201311864. https:\/\/doi.org\/10.1523\/JNEUROSCI.1700-16.2016","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"12800_CR24","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.3390\/ijms22115887","volume":"22","author":"R Han","year":"2021","unstructured":"Han R, Liang J, Zhou B (2021) Glucose metabolic dysfunction in neurodegenerative diseases-new mechanistic insights and the potential of hypoxia as a prospective therapy targeting metabolic reprogramming. Int J Mol Sci 22:5887. https:\/\/doi.org\/10.3390\/ijms22115887","journal-title":"Int J Mol Sci"},{"key":"12800_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s100480050002","volume":"1","author":"JM Shoffner","year":"1997","unstructured":"Shoffner JM (1997) Oxidative phosphorylation defects and Alzheimer\u2019s disease. Neurogenetics 1:13\u201319. https:\/\/doi.org\/10.1007\/s100480050002","journal-title":"Neurogenetics"},{"key":"12800_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3233\/JAD-2010-100966","volume":"23","author":"M Cuadrado-Tejedor","year":"2011","unstructured":"Cuadrado-Tejedor M, Vilari\u00f1o M, Cabodevilla F et al (2011) Enhanced expression of the voltage-dependent anion channel 1 (VDAC1) in Alzheimer\u2019s Disease transgenic mice: an insight into the pathogenic effects of amyloid-\u03b2. J Alzheimers Dis 23:195\u2013206. https:\/\/doi.org\/10.3233\/JAD-2010-100966","journal-title":"J Alzheimers Dis"},{"key":"12800_CR27","doi-asserted-by":"publisher","first-page":"37245","DOI":"10.1074\/jbc.M112.366195","volume":"287","author":"JT Newington","year":"2012","unstructured":"Newington JT, Rappon T, Albers S et al (2012) Overexpression of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase A in nerve cells confers resistance to amyloid \u03b2 and other toxins by decreasing mitochondrial respiration and reactive oxygen species production. J Biol Chem 287:37245\u201337258. https:\/\/doi.org\/10.1074\/jbc.M112.366195","journal-title":"J Biol Chem"},{"key":"12800_CR28","doi-asserted-by":"publisher","first-page":"18033","DOI":"10.18632\/aging.203330","volume":"13","author":"R Santangelo","year":"2021","unstructured":"Santangelo R, Giuffrida ML, Satriano C et al (2021) \u03b2-amyloid monomers drive up neuronal aerobic glycolysis in response to energy stressors. Aging 13:18033\u201318050. https:\/\/doi.org\/10.18632\/aging.203330","journal-title":"Aging"},{"key":"12800_CR29","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1039\/C4CS00038B","volume":"43","author":"SA Yuzwa","year":"2014","unstructured":"Yuzwa SA, Vocadlo DJ (2014) O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer\u2019s disease and beyond. Chem Soc Rev 43:6839\u20136858. https:\/\/doi.org\/10.1039\/C4CS00038B","journal-title":"Chem Soc Rev"},{"key":"12800_CR30","doi-asserted-by":"publisher","first-page":"661368","DOI":"10.3389\/fnmol.2021.661368","volume":"14","author":"F-X Cantrelle","year":"2021","unstructured":"Cantrelle F-X, Loyens A, Trivelli X et al (2021) Phosphorylation and O-GlcNAcylation of the PHF-1 epitope of tau protein induce local conformational changes of the c-terminus and modulate tau self-assembly into fibrillar aggregates. Front Mol Neurosci 14:661368. https:\/\/doi.org\/10.3389\/fnmol.2021.661368","journal-title":"Front Mol Neurosci"},{"key":"12800_CR31","doi-asserted-by":"publisher","first-page":"10804","DOI":"10.1073\/pnas.0400348101","volume":"101","author":"F Liu","year":"2004","unstructured":"Liu F, Iqbal K, Grundke-Iqbal I et al (2004) O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 101:10804\u201310809. https:\/\/doi.org\/10.1073\/pnas.0400348101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12800_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-9-42","volume":"9","author":"SA Yuzwa","year":"2014","unstructured":"Yuzwa SA, Shan X, Jones BA et al (2014) Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau\/APP mutant mice. Mol Neurodegener 9:42. https:\/\/doi.org\/10.1186\/1750-1326-9-42","journal-title":"Mol Neurodegener"},{"key":"12800_CR33","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.bbrc.2010.12.080","volume":"404","author":"KT Jacobsen","year":"2011","unstructured":"Jacobsen KT, Iverfeldt K (2011) O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-\u03b2 precursor protein (APP). Biochem Biophys Res Commun 404:882\u2013886. https:\/\/doi.org\/10.1016\/j.bbrc.2010.12.080","journal-title":"Biochem Biophys Res Commun"},{"key":"12800_CR34","doi-asserted-by":"publisher","first-page":"14719","DOI":"10.1074\/jbc.M113.525790","volume":"289","author":"EP Tan","year":"2014","unstructured":"Tan EP, Villar MT, E L, et al (2014) Altering O-linked \u03b2-N-acetylglucosamine cycling disrupts mitochondrial function. J Biol Chem 289:14719\u201314730. https:\/\/doi.org\/10.1074\/jbc.M113.525790","journal-title":"J Biol Chem"},{"key":"12800_CR35","doi-asserted-by":"publisher","first-page":"e201912077","DOI":"10.1083\/jcb.201912077","volume":"220","author":"H Basu","year":"2021","unstructured":"Basu H, Pekkurnaz G, Falk J et al (2021) FHL2 anchors mitochondria to actin and adapts mitochondrial dynamics to glucose supply. J Cell Biol 220:e201912077. https:\/\/doi.org\/10.1083\/jcb.201912077","journal-title":"J Cell Biol"},{"key":"12800_CR36","doi-asserted-by":"publisher","first-page":"30024","DOI":"10.1074\/jbc.M112.390682","volume":"287","author":"T Gawlowski","year":"2012","unstructured":"Gawlowski T, Suarez J, Scott B et al (2012) Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-\u03b2-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes. J Biol Chem 287:30024\u201330034. https:\/\/doi.org\/10.1074\/jbc.M112.390682","journal-title":"J Biol Chem"},{"key":"12800_CR37","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/j.bbadis.2018.10.037","volume":"1865","author":"TS Pinho","year":"2019","unstructured":"Pinho TS, Correia SC, Perry G et al (2019) Diminished O-GlcNAcylation in Alzheimer\u2019s disease is strongly correlated with mitochondrial anomalies. Biochim Biophys Acta Mol Basis Dis 1865:2048\u20132059. https:\/\/doi.org\/10.1016\/j.bbadis.2018.10.037","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"12800_CR38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fnagi.2017.00345","volume":"9","author":"BJ Neth","year":"2017","unstructured":"Neth BJ, Craft S (2017) Insulin resistance and Alzheimer\u2019s Disease: bioenergetic linkages. Front Aging Neurosci 9:345. https:\/\/doi.org\/10.3389\/fnagi.2017.00345","journal-title":"Front Aging Neurosci"},{"key":"12800_CR39","doi-asserted-by":"publisher","first-page":"9987","DOI":"10.3390\/ijms22189987","volume":"22","author":"A S\u0119dzikowska","year":"2021","unstructured":"S\u0119dzikowska A, Szablewski L (2021) Insulin and insulin resistance in Alzheimer\u2019s Disease. Int J Mol Sci 22:9987. https:\/\/doi.org\/10.3390\/ijms22189987","journal-title":"Int J Mol Sci"},{"key":"12800_CR40","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jamaneurol.2015.0613","volume":"72","author":"AA Willette","year":"2015","unstructured":"Willette AA, Bendlin BB, Starks EJ et al (2015) Association of insulin resistance with cerebral glucose uptake in late middle-aged adults at risk for Alzheimer Disease. JAMA Neurol 72:1013\u20131020. https:\/\/doi.org\/10.1001\/jamaneurol.2015.0613","journal-title":"JAMA Neurol"},{"key":"12800_CR41","doi-asserted-by":"publisher","first-page":"18742","DOI":"10.1074\/jbc.M109.011015","volume":"284","author":"W-Q Zhao","year":"2009","unstructured":"Zhao W-Q, Lacor PN, Chen H et al (2009) Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}. J Biol Chem 284:18742\u201318753. https:\/\/doi.org\/10.1074\/jbc.M109.011015","journal-title":"J Biol Chem"},{"key":"12800_CR42","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3390\/cells10051236","volume":"10","author":"J Burillo","year":"2021","unstructured":"Burillo J, Marqu\u00e9s P, Jim\u00e9nez B et al (2021) Insulin resistance and diabetes mellitus in Alzheimer\u2019s disease. Cells 10:1236. https:\/\/doi.org\/10.3390\/cells10051236","journal-title":"Cells"},{"key":"12800_CR43","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1523\/JNEUROSCI.21-08-02561.2001","volume":"21","author":"L Gasparini","year":"2001","unstructured":"Gasparini L, Gouras GK, Wang R et al (2001) Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci Off J Soc Neurosci 21:2561\u20132570. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-08-02561.2001","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"12800_CR44","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.2337\/db11-1735","volume":"61","author":"SM Son","year":"2012","unstructured":"Son SM, Song H, Byun J et al (2012) Altered APP processing in insulin-resistant conditions is mediated by autophagosome accumulation via the inhibition of mammalian target of rapamycin pathway. Diabetes 61:3126\u20133138. https:\/\/doi.org\/10.2337\/db11-1735","journal-title":"Diabetes"},{"key":"12800_CR45","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.4161\/auto.21861","volume":"8","author":"SM Son","year":"2012","unstructured":"Son SM, Song H, Byun J et al (2012) Accumulation of autophagosomes contributes to enhanced amyloidogenic APP processing under insulin-resistant conditions. Autophagy 8:1842\u20131844. https:\/\/doi.org\/10.4161\/auto.21861","journal-title":"Autophagy"},{"key":"12800_CR46","doi-asserted-by":"publisher","first-page":"e32792","DOI":"10.1371\/journal.pone.0032792","volume":"7","author":"L Devi","year":"2012","unstructured":"Devi L, Alldred MJ, Ginsberg SD, Ohno M (2012) Mechanisms underlying insulin deficiency-induced acceleration of \u03b2-amyloidosis in a mouse model of Alzheimer\u2019s disease. PLoS ONE 7:e32792. https:\/\/doi.org\/10.1371\/journal.pone.0032792","journal-title":"PLoS ONE"},{"key":"12800_CR47","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","volume":"29","author":"Q-L Ma","year":"2009","unstructured":"Ma Q-L, Yang F, Rosario ER et al (2009) Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci Off J Soc Neurosci 29:9078\u20139089. https:\/\/doi.org\/10.1523\/JNEUROSCI.1071-09.2009","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"12800_CR48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1677\/joe.0.1670107","volume":"167","author":"J Shao","year":"2000","unstructured":"Shao J, Yamashita H, Qiao L, Friedman JE (2000) Decreased Akt kinase activity and insulin resistance in C57BL\/KsJ-Leprdb\/db mice. J Endocrinol 167:107\u2013115. https:\/\/doi.org\/10.1677\/joe.0.1670107","journal-title":"J Endocrinol"},{"key":"12800_CR49","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1210\/en.2012-1661","volume":"154","author":"G Pandini","year":"2013","unstructured":"Pandini G, Pace V, Copani A et al (2013) Insulin has multiple antiamyloidogenic effects on human neuronal cells. Endocrinology 154:375\u2013387. https:\/\/doi.org\/10.1210\/en.2012-1661","journal-title":"Endocrinology"},{"key":"12800_CR50","doi-asserted-by":"publisher","first-page":"RC221","DOI":"10.1523\/JNEUROSCI.22-10-j0001.2002","volume":"22","author":"L Xie","year":"2002","unstructured":"Xie L, Helmerhorst E, Taddei K et al (2002) Alzheimer\u2019s beta-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci Off J Soc Neurosci 22:RC221. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-10-j0001.2002","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"12800_CR51","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1096\/fj.06-7703com","volume":"22","author":"W-Q Zhao","year":"2008","unstructured":"Zhao W-Q, De Felice FG, Fernandez S et al (2008) Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J Off Publ Fed Am Soc Exp Biol 22:246\u2013260. https:\/\/doi.org\/10.1096\/fj.06-7703com","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"12800_CR52","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3233\/jad-2002-4504","volume":"4","author":"X Ling","year":"2002","unstructured":"Ling X, Martins RN, Racchi M et al (2002) Amyloid beta antagonizes insulin promoted secretion of the amyloid beta-protein precursor. J Alzheimers Dis JAD 4:369\u2013374. https:\/\/doi.org\/10.3233\/jad-2002-4504","journal-title":"J Alzheimers Dis JAD"},{"key":"12800_CR53","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI57256","volume":"122","author":"TR Bomfim","year":"2012","unstructured":"Bomfim TR, Forny-Germano L, Sathler LB et al (2012) An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease- associated A\u03b2 oligomers. J Clin Invest 122:1339\u20131353. https:\/\/doi.org\/10.1172\/JCI57256","journal-title":"J Clin Invest"},{"key":"12800_CR54","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","volume":"20","author":"V Vekrellis","year":"2000","unstructured":"Vekrellis V, Ye Z, Qiu WQ et al (2000) Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci Off J Soc Neurosci 20:1657\u20131665. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-05-01657.2000","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"12800_CR55","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1073\/pnas.0230450100","volume":"100","author":"W Farris","year":"2003","unstructured":"Farris W, Mansourian S, Chang Y et al (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A 100:4162\u20134167. https:\/\/doi.org\/10.1073\/pnas.0230450100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12800_CR56","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","volume":"40","author":"MA Leissring","year":"2003","unstructured":"Leissring MA, Farris W, Chang AY et al (2003) Enhanced proteolysis of \u03b2-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40:1087\u20131093. https:\/\/doi.org\/10.1016\/S0896-6273(03)00787-6","journal-title":"Neuron"},{"key":"12800_CR57","doi-asserted-by":"publisher","first-page":"11120","DOI":"10.1523\/JNEUROSCI.2860-04.2004","volume":"24","author":"L Zhao","year":"2004","unstructured":"Zhao L, Teter B, Morihara T et al (2004) Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer\u2019s disease intervention. J Neurosci 24:11120\u201311126. https:\/\/doi.org\/10.1523\/JNEUROSCI.2860-04.2004","journal-title":"J Neurosci"},{"key":"12800_CR58","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1096\/fj.03-0978fje","volume":"18","author":"L Ho","year":"2004","unstructured":"Ho L, Qin W, Pompl PN et al (2004) Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease. FASEB J 18:902\u2013904. https:\/\/doi.org\/10.1096\/fj.03-0978fje","journal-title":"FASEB J"},{"key":"12800_CR59","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","volume":"72","author":"MD Weingarten","year":"1975","unstructured":"Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A 72:1858\u20131862. https:\/\/doi.org\/10.1073\/pnas.72.5.1858","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12800_CR60","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F et al (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models. Cell 142:387\u2013397. https:\/\/doi.org\/10.1016\/j.cell.2010.06.036","journal-title":"Cell"},{"key":"12800_CR61","doi-asserted-by":"publisher","first-page":"19547","DOI":"10.1074\/jbc.272.31.19547","volume":"272","author":"M Hong","year":"1997","unstructured":"Hong M, Lee VM (1997) Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 272:19547\u201319553. https:\/\/doi.org\/10.1074\/jbc.272.31.19547","journal-title":"J Biol Chem"},{"key":"12800_CR62","doi-asserted-by":"crossref","unstructured":"Tau Phosphorylation by GSK3 in different conditions. https:\/\/www.hindawi.com\/journals\/ijad\/2012\/578373\/. Accessed 29 Dec 2022","DOI":"10.1155\/2012\/578373"},{"key":"12800_CR63","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1242\/jcs.00384","volume":"116","author":"BW Doble","year":"2003","unstructured":"Doble BW, Woodgett JR (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116:1175\u20131186. https:\/\/doi.org\/10.1242\/jcs.00384","journal-title":"J Cell Sci"},{"key":"12800_CR64","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1084\/jem.20170979","volume":"214","author":"M Gratuze","year":"2017","unstructured":"Gratuze M, Planel E (2017) Regulation of brain insulin signaling: a new function for tau. J Exp Med 214:2171\u20132173. https:\/\/doi.org\/10.1084\/jem.20170979","journal-title":"J Exp Med"},{"key":"12800_CR65","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1084\/jem.20161731","volume":"214","author":"E Marciniak","year":"2017","unstructured":"Marciniak E, Leboucher A, Caron E et al (2017) Tau deletion promotes brain insulin resistance. J Exp Med 214:2257\u20132269. https:\/\/doi.org\/10.1084\/jem.20161731","journal-title":"J Exp Med"},{"key":"12800_CR66","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1042\/BST20051019","volume":"33","author":"D Mokranjac","year":"2005","unstructured":"Mokranjac D, Neupert W (2005) Protein import into mitochondria. Biochem Soc Trans 33:1019\u20131023. https:\/\/doi.org\/10.1042\/BST20051019","journal-title":"Biochem Soc Trans"},{"key":"12800_CR67","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3233\/JAD-170139","volume":"59","author":"A Stoccoro","year":"2017","unstructured":"Stoccoro A, Siciliano G, Migliore L, Copped\u00e8 F (2017) Decreased methylation of the mitochondrial D-loop region in late-onset Alzheimer\u2019s disease. J Alzheimers Dis 59:559\u2013564. https:\/\/doi.org\/10.3233\/JAD-170139","journal-title":"J Alzheimers Dis"},{"key":"12800_CR68","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ajpath.2015.10.004","volume":"186","author":"M Blanch","year":"2016","unstructured":"Blanch M, Mosquera JL, Ansoleaga B et al (2016) Altered mitochondrial DNA methylation pattern in Alzheimer disease-related pathology and in Parkinson disease. Am J Pathol 186:385\u2013397. https:\/\/doi.org\/10.1016\/j.ajpath.2015.10.004","journal-title":"Am J Pathol"},{"key":"12800_CR69","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ymgme.2013.07.012","volume":"110","author":"V Iacobazzi","year":"2013","unstructured":"Iacobazzi V, Castegna A, Infantino V, Andria G (2013) Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. Mol Genet Metab 110:25\u201334. https:\/\/doi.org\/10.1016\/j.ymgme.2013.07.012","journal-title":"Mol Genet Metab"},{"key":"12800_CR70","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.mad.2013.08.005","volume":"134","author":"MA Bradley-Whitman","year":"2013","unstructured":"Bradley-Whitman MA, Lovell MA (2013) Epigenetic changes in the progression of Alzheimer\u2019s disease. Mech Ageing Dev 134:486\u2013495. https:\/\/doi.org\/10.1016\/j.mad.2013.08.005","journal-title":"Mech Ageing Dev"},{"key":"12800_CR71","doi-asserted-by":"publisher","first-page":"106257","DOI":"10.1016\/j.nbd.2023.106257","volume":"185","author":"MJ Armstrong","year":"2023","unstructured":"Armstrong MJ, Jin Y, Vattathil SM et al (2023) Role of TET1-mediated epigenetic modulation in Alzheimer\u2019s disease. Neurobiol Dis 185:106257. https:\/\/doi.org\/10.1016\/j.nbd.2023.106257","journal-title":"Neurobiol Dis"},{"key":"12800_CR72","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.2217\/epi-2020-0041","volume":"12","author":"A Stoccoro","year":"2020","unstructured":"Stoccoro A, Tannorella P, Migliore L, Copped\u00e8 F (2020) Polymorphisms of genes required for methionine synthesis and DNA methylation influence mitochondrial DNA methylation. Epigenomics 12:1003\u20131012. https:\/\/doi.org\/10.2217\/epi-2020-0041","journal-title":"Epigenomics"},{"key":"12800_CR73","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1006\/geno.1994.1525","volume":"23","author":"M Corral-Debrinski","year":"1994","unstructured":"Corral-Debrinski M, Horton T, Lott MT et al (1994) Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 23:471\u2013476. https:\/\/doi.org\/10.1006\/geno.1994.1525","journal-title":"Genomics"},{"key":"12800_CR74","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1016\/j.neurobiolaging.2011.08.009","volume":"33","author":"KJ Krishnan","year":"2012","unstructured":"Krishnan KJ, Ratnaike TE, De Gruyter HLM et al (2012) Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer\u2019s disease. Neurobiol Aging 33:2210\u20132214. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.08.009","journal-title":"Neurobiol Aging"},{"key":"12800_CR75","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/S0891-5849(02)01113-9","volume":"33","author":"G Perry","year":"2002","unstructured":"Perry G, Nunomura A, Hirai K et al (2002) Is oxidative damage the fundamental pathogenic mechanism of Alzheimer\u2019s and other neurodegenerative diseases? Free Radic Biol Med 33:1475\u20131479. https:\/\/doi.org\/10.1016\/S0891-5849(02)01113-9","journal-title":"Free Radic Biol Med"},{"key":"12800_CR76","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ana.410360510","volume":"36","author":"P Mecocci","year":"1994","unstructured":"Mecocci P, MacGarvey U, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer\u2019s disease. Ann Neurol 36:747\u2013751. https:\/\/doi.org\/10.1002\/ana.410360510","journal-title":"Ann Neurol"},{"key":"12800_CR77","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ana.24709","volume":"80","author":"JG Hoekstra","year":"2016","unstructured":"Hoekstra JG, Hipp MJ, Montine TJ, Kennedy SR (2016) Mitochondrial DNA mutations increase in early stage Alzheimer disease and are inconsistent with oxidative damage. Ann Neurol 80:301\u2013306. https:\/\/doi.org\/10.1002\/ana.24709","journal-title":"Ann Neurol"},{"key":"12800_CR78","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pneurobio.2011.04.013","volume":"94","author":"DK Jeppesen","year":"2011","unstructured":"Jeppesen DK, Bohr VA, Stevnsner T (2011) DNA repair deficiency in neurodegeneration. Prog Neurobiol 94:166\u2013200. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.04.013","journal-title":"Prog Neurobiol"},{"key":"12800_CR79","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mad.2016.04.005","volume":"161","author":"Y Hou","year":"2017","unstructured":"Hou Y, Song H, Croteau DL et al (2017) Genome instability in Alzheimer disease. Mech Ageing Dev 161:83\u201394. https:\/\/doi.org\/10.1016\/j.mad.2016.04.005","journal-title":"Mech Ageing Dev"},{"key":"12800_CR80","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/nar\/gku1356","volume":"43","author":"P Sykora","year":"2015","unstructured":"Sykora P, Misiak M, Wang Y et al (2015) DNA polymerase \u03b2 deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes. Nucleic Acids Res 43:943\u2013959. https:\/\/doi.org\/10.1093\/nar\/gku1356","journal-title":"Nucleic Acids Res"},{"key":"12800_CR81","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3233\/JAD-151040","volume":"54","author":"S Martire","year":"2016","unstructured":"Martire S, Fuso A, Mosca L et al (2016) Bioenergetic impairment in animal and cellular models of Alzheimer\u2019s disease: PARP-1 inhibition rescues metabolic dysfunctions. J Alzheimers Dis 54:307\u2013324. https:\/\/doi.org\/10.3233\/JAD-151040","journal-title":"J Alzheimers Dis"},{"key":"12800_CR82","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mad.2015.04.001","volume":"146\u2013148","author":"S Martire","year":"2015","unstructured":"Martire S, Mosca L, d\u2019Erme M (2015) PARP-1 involvement in neurodegeneration: A focus on Alzheimer\u2019s and Parkinson\u2019s diseases. Mech Ageing Dev 146\u2013148:53\u201364. https:\/\/doi.org\/10.1016\/j.mad.2015.04.001","journal-title":"Mech Ageing Dev"},{"key":"12800_CR83","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12035-012-8258-9","volume":"46","author":"JB Strosznajder","year":"2012","unstructured":"Strosznajder JB, Czapski GA, Adamczyk A, Strosznajder RP (2012) Poly(ADP-ribose) polymerase-1 in amyloid beta toxicity and Alzheimer\u2019s disease. Mol Neurobiol 46:78\u201384. https:\/\/doi.org\/10.1007\/s12035-012-8258-9","journal-title":"Mol Neurobiol"},{"key":"12800_CR84","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2174\/1568026615666150827095102","volume":"16","author":"HM Wilkins","year":"2016","unstructured":"Wilkins HM, Swerdlow RH (2016) Relationships between mitochondria and neuroinflammation: implications for Alzheimer\u2019s disease. Curr Top Med Chem 16:849\u2013857. https:\/\/doi.org\/10.2174\/1568026615666150827095102","journal-title":"Curr Top Med Chem"},{"key":"12800_CR85","doi-asserted-by":"publisher","first-page":"467","DOI":"10.4172\/2155-9899.1000467","volume":"7","author":"AE Russell","year":"2016","unstructured":"Russell AE, Doll DN (2016) TNF-\u03b1 and beyond: rapid mitochondrial dysfunction mediates TNF-\u03b1-induced neurotoxicity. J Clin Cell Immunol 7:467. https:\/\/doi.org\/10.4172\/2155-9899.1000467","journal-title":"J Clin Cell Immunol"},{"key":"12800_CR86","doi-asserted-by":"publisher","first-page":"33888","DOI":"10.1074\/jbc.M702969200","volume":"282","author":"M Chen","year":"2007","unstructured":"Chen M, Guerrero AD, Huang L et al (2007) Caspase-9-induced mitochondrial disruption through cleavage of anti-apoptotic BCL-2 family members. J Biol Chem 282:33888\u201333895. https:\/\/doi.org\/10.1074\/jbc.M702969200","journal-title":"J Biol Chem"},{"key":"12800_CR87","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.lfs.2017.05.023","volume":"182","author":"C Jian","year":"2017","unstructured":"Jian C, Lu M, Zhang Z et al (2017) miR-34a knockout attenuates cognitive deficits in APP\/PS1 mice through inhibition of the amyloidogenic processing of APP. Life Sci 182:104\u2013111. https:\/\/doi.org\/10.1016\/j.lfs.2017.05.023","journal-title":"Life Sci"},{"key":"12800_CR88","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.brainresbull.2009.08.006","volume":"80","author":"X Wang","year":"2009","unstructured":"Wang X, Liu P, Zhu H et al (2009) miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer\u2019s disease, inhibits bcl2 translation. Brain Res Bull 80:268\u2013273. https:\/\/doi.org\/10.1016\/j.brainresbull.2009.08.006","journal-title":"Brain Res Bull"},{"key":"12800_CR89","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3390\/cells9061345","volume":"9","author":"A John","year":"2020","unstructured":"John A, Kubosumi A, Reddy PH (2020) Mitochondrial MicroRNAs in aging and neurodegenerative diseases. Cells 9:1345. https:\/\/doi.org\/10.3390\/cells9061345","journal-title":"Cells"},{"key":"12800_CR90","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.brainres.2016.09.047","volume":"1652","author":"R Zhang","year":"2016","unstructured":"Zhang R, Zhou H, Jiang L et al (2016) MiR-195 dependent roles of mitofusin2 in the mitochondrial dysfunction of hippocampal neurons in SAMP8 mice. Brain Res 1652:135\u2013143. https:\/\/doi.org\/10.1016\/j.brainres.2016.09.047","journal-title":"Brain Res"},{"key":"12800_CR91","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1152\/physrev.00062.2017","volume":"99","author":"GA Dienel","year":"2019","unstructured":"Dienel GA (2019) Brain glucose metabolism: integration of energetics with function. Physiol Rev 99:949\u20131045. https:\/\/doi.org\/10.1152\/physrev.00062.2017","journal-title":"Physiol Rev"},{"key":"12800_CR92","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.3390\/ijms22094914","volume":"22","author":"R Cascella","year":"2021","unstructured":"Cascella R, Cecchi C (2021) Calcium dyshomeostasis in Alzheimer\u2019s disease pathogenesis. Int J Mol Sci 22:4914. https:\/\/doi.org\/10.3390\/ijms22094914","journal-title":"Int J Mol Sci"},{"key":"12800_CR93","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1152\/physrev.00032.2008","volume":"89","author":"M Brini","year":"2009","unstructured":"Brini M, Carafoli E (2009) Calcium pumps in health and disease. Physiol Rev 89:1341\u20131378. https:\/\/doi.org\/10.1152\/physrev.00032.2008","journal-title":"Physiol Rev"},{"key":"12800_CR94","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3389\/fnagi.2019.00253","volume":"11","author":"MR Holahan","year":"2019","unstructured":"Holahan MR, Tzakis N, Oliveira FA (2019) Developmental aspects of glucose and calcium availability on the persistence of memory function over the lifespan. Front Aging Neurosci 11:253. https:\/\/doi.org\/10.3389\/fnagi.2019.00253","journal-title":"Front Aging Neurosci"},{"key":"12800_CR95","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1002\/alz.13366","volume":"19","author":"Y Liao","year":"2023","unstructured":"Liao Y, Wang Y, Tao Q-Q et al (2023) CALHM2 V136G polymorphism reduces astrocytic ATP release and is associated with depressive symptoms and Alzheimer\u2019s disease risk. Alzheimers Dement J Alzheimers Assoc 19:4407\u20134420. https:\/\/doi.org\/10.1002\/alz.13366","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"12800_CR96","unstructured":"Structure and assembly of calcium homeostasis modulator proteins\u2014PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/31988524\/. Accessed 24 Dec 2023"},{"key":"12800_CR97","doi-asserted-by":"publisher","unstructured":"Microglial Calcium Homeostasis Modulator 2: novel anti-neuroinflammation target for the treatment of neurodegenerative diseases|Neuroscience Bulletin. https:\/\/doi.org\/10.1007\/s12264-023-01153-3. Accessed 24 Dec 2023","DOI":"10.1007\/s12264-023-01153-3"},{"key":"12800_CR98","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tins.2020.10.004","volume":"44","author":"M Calvo-Rodriguez","year":"2021","unstructured":"Calvo-Rodriguez M, Bacskai BJ (2021) Mitochondria and calcium in Alzheimer\u2019s disease: from cell signaling to neuronal cell death. Trends Neurosci 44:136\u2013151. https:\/\/doi.org\/10.1016\/j.tins.2020.10.004","journal-title":"Trends Neurosci"},{"key":"12800_CR99","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1093\/hmg\/dds072","volume":"21","author":"M Manczak","year":"2012","unstructured":"Manczak M, Reddy PH (2012) Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer\u2019s disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum Mol Genet 21:2538\u20132547. https:\/\/doi.org\/10.1093\/hmg\/dds072","journal-title":"Hum Mol Genet"},{"key":"12800_CR100","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","volume":"20","author":"M Manczak","year":"2011","unstructured":"Manczak M, Calkins MJ, Reddy PH (2011) Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer\u2019s disease: implications for neuronal damage. Hum Mol Genet 20:2495\u20132509. https:\/\/doi.org\/10.1093\/hmg\/ddr139","journal-title":"Hum Mol Genet"},{"key":"12800_CR101","unstructured":"Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease|Nature Neuroscience. https:\/\/www.nature.com\/articles\/s41593-018-0332-9. Accessed 1 Nov 2023"},{"key":"12800_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107900","volume":"32","author":"R Mahoney","year":"2020","unstructured":"Mahoney R, Ochoa Thomas E, Ramirez P et al (2020) Pathogenic Tau Causes a Toxic Depletion of Nuclear Calcium. Cell Rep 32:107900. https:\/\/doi.org\/10.1016\/j.celrep.2020.107900","journal-title":"Cell Rep"},{"key":"12800_CR103","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/febs.15340","volume":"288","author":"N Esteras","year":"2021","unstructured":"Esteras N, Kundel F, Amodeo GF et al (2021) Insoluble tau aggregates induce neuronal death through modification of membrane ion conductance, activation of voltage-gated calcium channels and NADPH oxidase. FEBS J 288:127\u2013141. https:\/\/doi.org\/10.1111\/febs.15340","journal-title":"FEBS J"},{"key":"12800_CR104","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41593-018-0289-8","volume":"22","author":"MA Busche","year":"2019","unstructured":"Busche MA, Wegmann S, Dujardin S et al (2019) Tau impairs neural circuits, dominating amyloid-\u03b2 effects, in Alzheimer models in vivo. Nat Neurosci 22:57\u201364. https:\/\/doi.org\/10.1038\/s41593-018-0289-8","journal-title":"Nat Neurosci"},{"key":"12800_CR105","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1038\/s41467-020-16074-2","volume":"11","author":"M Calvo-Rodriguez","year":"2020","unstructured":"Calvo-Rodriguez M, Hou SS, Snyder AC et al (2020) Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer\u2019s disease. Nat Commun 11:2146. https:\/\/doi.org\/10.1038\/s41467-020-16074-2","journal-title":"Nat Commun"},{"key":"12800_CR106","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature12985","volume":"505","author":"JR Friedman","year":"2014","unstructured":"Friedman JR, Nunnari J (2014) Mitochondrial form and function. Nature 505:335\u2013343. https:\/\/doi.org\/10.1038\/nature12985","journal-title":"Nature"},{"key":"12800_CR107","doi-asserted-by":"publisher","first-page":"688789","DOI":"10.3389\/fcell.2021.688789","volume":"9","author":"S Xu","year":"2021","unstructured":"Xu S, Zhang X, Liu C et al (2021) Role of mitochondria in neurodegenerative diseases: from an epigenetic perspective. Front Cell Dev Biol 9:688789. https:\/\/doi.org\/10.3389\/fcell.2021.688789","journal-title":"Front Cell Dev Biol"},{"key":"12800_CR108","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/jnr.24781","volume":"99","author":"VK Medala","year":"2021","unstructured":"Medala VK, Gollapelli B, Dewanjee S et al (2021) Mitochondrial dysfunction, mitophagy, and role of dynamin-related protein 1 in Alzheimer\u2019s disease. J Neurosci Res 99:1120\u20131135. https:\/\/doi.org\/10.1002\/jnr.24781","journal-title":"J Neurosci Res"},{"key":"12800_CR109","doi-asserted-by":"publisher","first-page":"e49112","DOI":"10.1371\/journal.pone.0049112","volume":"7","author":"C-H Chou","year":"2012","unstructured":"Chou C-H, Lin C-C, Yang M-C et al (2012) GSK3beta-mediated Drp1 phosphorylation induced elongated mitochondrial morphology against oxidative stress. PLoS ONE 7:e49112. https:\/\/doi.org\/10.1371\/journal.pone.0049112","journal-title":"PLoS ONE"},{"key":"12800_CR110","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell AM, Youle RJ (2015) The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease. Neuron 85:257\u2013273. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.007","journal-title":"Neuron"},{"key":"12800_CR111","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1093\/brain\/awx258","volume":"140","author":"F Du","year":"2017","unstructured":"Du F, Yu Q, Yan S et al (2017) PINK1 signaling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer\u2019s disease. Brain 140:3233\u20133251. https:\/\/doi.org\/10.1093\/brain\/awx258","journal-title":"Brain"},{"key":"12800_CR112","doi-asserted-by":"publisher","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","volume":"29","author":"X Wang","year":"2009","unstructured":"Wang X, Su B, Lee H et al (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer\u2019s disease. J Neurosci Off J Soc Neurosci 29:9090\u20139103. https:\/\/doi.org\/10.1523\/JNEUROSCI.1357-09.2009","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"12800_CR113","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.bbadis.2015.12.018","volume":"1862","author":"R Kandimalla","year":"2016","unstructured":"Kandimalla R, Reddy PH (2016) Multiple faces of dynamin-related protein 1 and its role in Alzheimer\u2019s disease pathogenesis. Biochim Biophys Acta 1862:814\u2013828. https:\/\/doi.org\/10.1016\/j.bbadis.2015.12.018","journal-title":"Biochim Biophys Acta"},{"key":"12800_CR114","doi-asserted-by":"publisher","first-page":"5148","DOI":"10.1093\/hmg\/ddw330","volume":"25","author":"M Manczak","year":"2016","unstructured":"Manczak M, Kandimalla R, Fry D et al (2016) Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer\u2019s disease. Hum Mol Genet 25:5148\u20135166. https:\/\/doi.org\/10.1093\/hmg\/ddw330","journal-title":"Hum Mol Genet"},{"key":"12800_CR115","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.mito.2018.11.002","volume":"47","author":"K Panchal","year":"2019","unstructured":"Panchal K, Tiwari AK (2019) Mitochondrial dynamics, a key executioner in neurodegenerative diseases. Mitochondrion 47:151\u2013173. https:\/\/doi.org\/10.1016\/j.mito.2018.11.002","journal-title":"Mitochondrion"},{"key":"12800_CR116","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1093\/hmg\/ddy042","volume":"27","author":"M Manczak","year":"2018","unstructured":"Manczak M, Kandimalla R, Yin X, Reddy PH (2018) Hippocampal mutant APP and amyloid beta-induced cognitive decline, dendritic spine loss, defective autophagy, mitophagy and mitochondrial abnormalities in a mouse model of Alzheimer\u2019s disease. Hum Mol Genet 27:1332\u20131342. https:\/\/doi.org\/10.1093\/hmg\/ddy042","journal-title":"Hum Mol Genet"},{"key":"12800_CR117","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuroscience.2022.09.020","volume":"505","author":"G-S Chai","year":"2022","unstructured":"Chai G-S, Wu J-J, Gong J et al (2022) Activation of \u03b22-adrenergic receptor ameliorates amyloid-\u03b2-induced mitophagy defects and tau pathology in mice. Neuroscience 505:34\u201350. https:\/\/doi.org\/10.1016\/j.neuroscience.2022.09.020","journal-title":"Neuroscience"},{"key":"12800_CR118","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.neurobiolaging.2009.04.016","volume":"32","author":"V Srikanth","year":"2011","unstructured":"Srikanth V, Maczurek A, Phan T et al (2011) Advanced glycation endproducts and their receptor RAGE in Alzheimer\u2019s disease. Neurobiol Aging 32:763\u2013777. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.04.016","journal-title":"Neurobiol Aging"},{"key":"12800_CR119","doi-asserted-by":"publisher","first-page":"e673","DOI":"10.1038\/cddis.2013.180","volume":"4","author":"X-H Li","year":"2013","unstructured":"Li X-H, Du L-L, Cheng X-S et al (2013) Glycation exacerbates the neuronal toxicity of \u03b2-amyloid. Cell Death Dis 4:e673. https:\/\/doi.org\/10.1038\/cddis.2013.180","journal-title":"Cell Death Dis"},{"key":"12800_CR120","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/hmg\/ddx381","volume":"27","author":"R Kandimalla","year":"2018","unstructured":"Kandimalla R, Manczak M, Yin X et al (2018) Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer\u2019s disease. Hum Mol Genet 27:30\u201340. https:\/\/doi.org\/10.1093\/hmg\/ddx381","journal-title":"Hum Mol Genet"},{"key":"12800_CR121","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/j.cmet.2024.05.017","volume":"36","author":"D Kapogiannis","year":"2024","unstructured":"Kapogiannis D, Manolopoulos A, Mullins R et al (2024) Brain responses to intermittent fasting and the healthy living diet in older adults. Cell Metab 36:1668-1678.e5. https:\/\/doi.org\/10.1016\/j.cmet.2024.05.017","journal-title":"Cell Metab"},{"key":"12800_CR122","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/alz.12206","volume":"17","author":"M Fortier","year":"2021","unstructured":"Fortier M, Castellano C-A, St-Pierre V et al (2021) A ketogenic drink improves cognition in mild cognitive impairment: results of a 6-month RCT. Alzheimers Dement J Alzheimers Assoc 17:543\u2013552. https:\/\/doi.org\/10.1002\/alz.12206","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"12800_CR123","doi-asserted-by":"publisher","first-page":"17490","DOI":"10.1038\/s41598-017-17718-y","volume":"7","author":"M Gejl","year":"2017","unstructured":"Gejl M, Brock B, Egefjord L et al (2017) Blood\u2013brain glucose transfer in Alzheimer\u2019s disease: effect of GLP-1 analog treatment. Sci Rep 7:17490. https:\/\/doi.org\/10.1038\/s41598-017-17718-y","journal-title":"Sci Rep"},{"key":"12800_CR124","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.bbr.2018.08.006","volume":"356","author":"KT Watson","year":"2019","unstructured":"Watson KT, Wroolie TE, Tong G et al (2019) Neural correlates of liraglutide effects in persons at risk for Alzheimer\u2019s disease. Behav Brain Res 356:271\u2013278. https:\/\/doi.org\/10.1016\/j.bbr.2018.08.006","journal-title":"Behav Brain Res"},{"key":"12800_CR125","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1111\/jgs.18306","volume":"71","author":"H Tang","year":"2023","unstructured":"Tang H, Shao H, Shaaban CE et al (2023) Newer glucose-lowering drugs and risk of dementia: a systematic review and meta-analysis of observational studies. J Am Geriatr Soc 71:2096\u20132106. https:\/\/doi.org\/10.1111\/jgs.18306","journal-title":"J Am Geriatr Soc"},{"key":"12800_CR126","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","volume":"186","author":"M Jucker","year":"2023","unstructured":"Jucker M, Walker LC (2023) Alzheimer\u2019s disease: from immunotherapy to immunoprevention. Cell 186:4260\u20134270. https:\/\/doi.org\/10.1016\/j.cell.2023.08.021","journal-title":"Cell"},{"key":"12800_CR127","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.neuron.2024.02.017","volume":"112","author":"D Zhang","year":"2024","unstructured":"Zhang D, Zhang W, Ming C et al (2024) P-tau217 correlates with neurodegeneration in Alzheimer\u2019s disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy. Neuron 112:1676-1693.e12. https:\/\/doi.org\/10.1016\/j.neuron.2024.02.017","journal-title":"Neuron"},{"key":"12800_CR128","doi-asserted-by":"publisher","first-page":"1215807","DOI":"10.3389\/fpsyt.2023.1215807","volume":"14","author":"V Battini","year":"2023","unstructured":"Battini V, Cirnigliaro G, Leuzzi R et al (2023) The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression. Front Psychiatry 14:1215807. https:\/\/doi.org\/10.3389\/fpsyt.2023.1215807","journal-title":"Front Psychiatry"},{"key":"12800_CR129","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/dom.13373","volume":"20","author":"B Cao","year":"2018","unstructured":"Cao B, Rosenblat JD, Brietzke E et al (2018) Comparative efficacy and acceptability of antidiabetic agents for Alzheimer\u2019s disease and mild cognitive impairment: A systematic review and network meta-analysis. Diabetes Obes Metab 20:2467\u20132471. https:\/\/doi.org\/10.1111\/dom.13373","journal-title":"Diabetes Obes Metab"},{"key":"12800_CR130","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1007\/s11357-024-01118-y","volume":"46","author":"M Pszczo\u0142owska","year":"2024","unstructured":"Pszczo\u0142owska M, Walczak K, Mi\u015bk\u00f3w W et al (2024) Mitochondrial disorders leading to Alzheimer\u2019s disease\u2014perspectives of diagnosis and treatment. GeroScience 46:2977\u20132988. https:\/\/doi.org\/10.1007\/s11357-024-01118-y","journal-title":"GeroScience"},{"key":"12800_CR131","doi-asserted-by":"publisher","first-page":"166798","DOI":"10.1016\/j.bbadis.2023.166798","volume":"1869","author":"JS Bhatti","year":"2023","unstructured":"Bhatti JS, Kaur S, Mishra J et al (2023) Targeting dynamin-related protein-1 as a potential therapeutic approach for mitochondrial dysfunction in Alzheimer\u2019s disease. Biochim Biophys Acta BBA - Mol Basis Dis 1869:166798. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166798","journal-title":"Biochim Biophys Acta BBA - Mol Basis Dis"},{"key":"12800_CR132","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1002\/alz.13847","volume":"20","author":"Y Hou","year":"2024","unstructured":"Hou Y, Chu X, Park J-H et al (2024) Urolithin A improves Alzheimer\u2019s disease cognition and restores mitophagy and lysosomal functions. Alzheimers Dement J Alzheimers Assoc 20:4212\u20134233. https:\/\/doi.org\/10.1002\/alz.13847","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"12800_CR133","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3390\/antiox12020453","volume":"12","author":"X Bao","year":"2023","unstructured":"Bao X, Liu X, Wu Q et al (2023) Mitochondrial-targeted antioxidant MitoQ-mediated autophagy: a novel strategy for precise radiation protection. Antioxidants 12:453. https:\/\/doi.org\/10.3390\/antiox12020453","journal-title":"Antioxidants"},{"key":"12800_CR134","doi-asserted-by":"publisher","first-page":"103652","DOI":"10.1016\/j.drudis.2023.103652","volume":"28","author":"L Chacko","year":"2023","unstructured":"Chacko L, Chaudhary A, Singh B et al (2023) CRISPR-Cas9 in Alzheimer\u2019s disease: therapeutic trends, modalities, and challenges. Drug Discov Today 28:103652. https:\/\/doi.org\/10.1016\/j.drudis.2023.103652","journal-title":"Drug Discov Today"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12800-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12800-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12800-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T12:57:55Z","timestamp":1738155475000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12800-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":134,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["12800"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12800-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"2"}}